Efficacy of Virtual Reality in Upper Extremity Rehabilitation for Stroke Patients

Last updated: November 20, 2023
Sponsor: Bundang CHA Hospital
Overall Status: Active - Not Recruiting

Phase

N/A

Condition

Cerebral Ischemia

Stroke

Treatment

VR-based occupational therapy

Clinical Study ID

NCT06143176
2023-08-032
  • Ages 19-80
  • All Genders

Study Summary

To investigate the therapeutic effect of including virtual reality-based digital content in the upper limb motor function rehabilitation of stroke patients and to develop a treatment method to improve the upper limb motor function of stroke patients in the future.

Eligibility Criteria

Inclusion

  1. Inclusion Criteria for experimental group:
  2. Patients aged 19 to 80 years with unilateral stroke within 6 months of stroke onset
  3. Motor function evaluation: Patients showing moderate or lower upper limb dysfunctionwith an upper limb FMA (Fugl-Meyer Assessment) score of less than 58 points on theaffected side.
  4. Patients receiving or planning to receive exercise rehabilitation treatment 5 days aweek
  5. Inclusion Criteria for control group:
  1. Patients who have been admitted to our hospital's rehabilitation medicine department andreceived rehabilitation treatment within the past 5 years 2) Patients with unilateralstroke within 6 months of stroke onset who are between 19 and 80 years old at the time ofhospitalization 3) Patients who were admitted to the rehabilitation medicine department ofour hospital and received exercise rehabilitation treatment for 4 weeks, 5 days a week 4)Patients with similar characteristics below compared to the test group
  • Age: Difference within 5 years
  • Gait function: Functional Ambulatory Category (FAC)
  • Upper extremity function: Fugl-Meyer Assessment (FMA) difference within 6 points
  • Cognitive function: Korean Version of Mini Mental State Examination (K-MMSE)difference within 5 points
  • Daily living skills: Korean Version of Modified Barthel Index (K-MBI) differencewithin 10 points

Exclusion

  1. Exclusion Criteria:
  2. Accompanying existing serious neurogenic disease
  3. Cases accompanied by existing serious psychiatric diseases such as majorschizophrenia, bipolar disorder, dementia, etc.
  4. Cases where it is difficult to understand task performance due to severecognitive decline (Korean Mini-Mental State Examination, K-MMSE 10 points orless)
  5. If there are difficulties in conducting research
  6. Other patients who are judged by the principal investigator to have difficultyparticipating in this study.

Study Design

Total Participants: 10
Treatment Group(s): 1
Primary Treatment: VR-based occupational therapy
Phase:
Study Start date:
November 27, 2023
Estimated Completion Date:
November 27, 2024